US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 72.180
  • +0.960+1.35%
Close Feb 14 16:00 ET
  • 73.670
  • +1.490+2.06%
Pre 05:18 ET
2.42BMarket Cap77.61P/E (TTM)

TransMedics Key Stats

TransMedics Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
109.49M
+34.88%
EPS
0.16
+30.17%
Buy

Jan 31, 2025

TransMedics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 119.399M--
Feb 27, 20252024/Q4-- / 109.490M--
Oct 28, 20242024/Q3108.761M / 114.997M--
--2024/Q2114.305M / 98.957M--
Apr 30, 20242024/Q196.850M / 83.608M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 119.399M--
Feb 27, 20252024/Q4-- / 109.490M--
Oct 28, 20242024/Q3108.761M / 114.997M--
--2024/Q2114.305M / 98.957M--
Apr 30, 20242024/Q196.850M / 83.608M--

Unlock Free Earnings Estimates

TransMedics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 31, 2025

Buy

  • Buy

    62.50%
  • Hold

    37.50%
  • Sell

    0.00%

Price Target

No Data